New Centres Sought for C. difficile Study
The RAPID trial is looking to open more recruitment centres. We are examining the effectiveness of Rifaximin in preventing recurrence of C. difficile infection. Professor Robin Spiller is the Chief Investigator of this NIHR portfolio study (UKCRN ID: 12990), being sponsored by the University of Nottingham.
- Further information [ 195 kb ]